Clinical Oral Implants Research · 2010 · 61 citations · 35 references
MedicinePeriodontologySurgeryBone GraftingBone MetabolismImplant SurgeryBone HealingBone RegenerationOsseointegration MonitoringOsteoblast BiologyOsteoblast FunctionOsteogenesisBone Healing BiologyBone Healing BiomarkersGrowth FactorsHealing Tissue FormationOsseointegrationPeri-implant Bone HealingPro-inflammatory Cytokine CascadesTissue Healing Response
OBJECTIVE: Central to the process of osseointegration is the recruitment of mesenchymal progenitor cells to the healing site, their proliferation and differentiation to bone synthesising osteoblasts. The process is under the control of pro-inflammatory cytokines and growth factors. The aim of this study was to monitor these key stages of osseointegration and the signalling milieu during bone healing around implants placed in healthy and diabetic bone. METHODS: Implants were placed into the sockets of incisors extracted from the mandibles of normal Wistar and diabetic Goto-Kakizaki rats. Mandibles 1-12 weeks post-insertion of the implant were examined by histochemistry and immunocytochemistry to localise the presence of Stro-1- positive mesenchymal progenitor cells, proliferating cellular nuclear antigen proliferative cells, osteopontin and osteocalcin, macrophages, pro-inflammatory cytokines interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and tumour growth factor (TGF)-β1. Image analysis provided a semi-quantification of positively expressing cells. RESULTS: Histological staining identified a delay in the formation of mineralised bone around implants placed in diabetic animals. Within the diabetic bone, the migration of Stro-1 mesenchymal cells in the healing tissue appeared to be unaffected. However, in the diabetic healing bone, the onset of cell proliferation and osteoblast differentiation were delayed and subsequently prolonged compared with normal bone. Similar patterns of change were observed in diabetic bone for the presence of IL-1β, TNF-α, macrophages and TGF-β1. CONCLUSION: The observed alterations in the extracellular presence of pro-inflammatory cytokines, macrophages and growth factors within diabetic tissues that correlate to changes in the signalling milieu, may affect the proliferation and differentiation of mesenchymal progenitor cells in the osseointegration process.
35
Increased bone formation in osteocalcin-deficient mice
Patricia Ducy, Christelle Desbois, Brendan F. Boyce et al. · Nature · 1996 · 1.7K citations · Full text
Understanding Peri‐Implant Endosseous Healing
John E. Davies · Journal of Dental Education · 2003 · 1.1K citations
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes
Joseph J. Senn, Peter Klover, Irena Nowak et al. · Diabetes · 2002 · 877 citations · Full text
Osteopontin--a possible anchor of osteoclasts to bone.
Finn P. Reinholt, Kjell Hultenby, Å Oldberg et al. · Proceedings of the National Academy of Sciences · 1990 · 827 citations